S1 Guideline: Diagnosis and therapy of vitiligo
Authors:
Open Access
- 4 March 2022
- journal article
- research article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 20 (3) , 365-378
Abstract
Summary: Vitiligo is a common skin disorder characterized by immune‐mediated destruction of melanocytes. Non‐segmental vitiligo, the most common clinical subtype, has usually a chronic course and often results in significant psychosocial consequences for the affected patient. Early recognition, awareness of comorbidity, precise assessment of disease extent and activity, evaluation of impairment of quality of life as well as rapid initiation of treatment based on currently available evidence‐based therapies are crucial cornerstones in the management of vitiligo. This S1 guideline helps German dermatologists to better diagnose and treat vitiligo.Keywords
This publication has 132 references indexed in Scilit:
- Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partnersBritish Journal of Dermatology, 2012
- Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized studyBritish Journal of Dermatology, 2012
- The prevalence of thyroid disease in patients with vitiligo: a systematic reviewBritish Journal of Dermatology, 2012
- Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus ConferencePigment Cell & Melanoma Research, 2012
- Skin camouflageBMJ, 2012
- Vitiligo Treatment with Monochromatic Excimer Light and Tacrolimus: Results of an Open Randomized Controlled StudyPhotomedicine and Laser Surgery, 2012
- 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized studyBritish Journal of Dermatology, 2010
- Treatment of vitiligo vulgaris with narrow‐band UVB and oral Polypodium leucotomos extract: a randomized double‐blind placebo‐controlled studyJournal of the European Academy of Dermatology and Venereology, 2007
- Infliximab-Induced VitiligoDermatology, 2004
- Parametric Modeling of Narrowband UV-B Phototherapy for Vitiligo Using a Novel Quantitative ToolArchives of Dermatology, 2004